Table 6.
Group | Hexokinase (n moles of glucose-6-phosphate formed/min/mg/protein) | Aldolase (n moles of glyceraldehyde formed/min/mg protein) | Phosphoglucoisomerase (n moles of fructose formed/min/mg protein) |
---|---|---|---|
C | 291.64 ± 10.52 | 222.7 ± 13.64 | 31.64 ± 3.67 |
A | 82.7 ± 5.05 | 286.26 ± 19.86 | 18.48 ± 2.90 |
A + M100 | 152.46 ± 6.88∗ | 263.86 ± 11.38∗ | 24.36 ± 2.31∗ |
A + M200 | 234.1 ± 7.3∗ | 243.06 ± 10.98∗ | 27.02 ± 2.99∗ |
A + M500 | 274.94 ± 9.61∗ | 229.54 ± 4.75∗ | 30.3 ± 1.77∗ |
A + G500 | 142.32 ± 10.59∗ | 267.5 ± 6.04∗ | 24.98 ± 2.08∗ |
A + G750 | 221.92 ± 7.69∗ | 241.94 ± 10.34∗ | 30.16 ± 2.26∗ |
A + G1000 | 260.28 ± 8.788∗ | 224.68 ± 7.75∗ | 28.68 ± 2.07∗ |
M100 | 292.56 ± 17.18 | 225.74 ± 9.55 | 28.4 ± 3.09 |
M200 | 290.56 ± 8.18 | 212.58 ± 2.27 | 29.62 ± 2.83 |
M500 | 288.36 ± 9.30 | 225.38 ± 7.98 | 30.7 ± 1.93 |
G 500 | 291.16 ± 6.76 | 219.34 ± 7.28 | 29.98 ± 1.23 |
G 750 | 288 ± 13.13 | 223.74 ± 8.75 | 32 ± 1.86 |
G 1000 | 279.6 ± 12.72 | 219.42 ± 8.52 | 32.8 ± 2.07 |
∗ p < 0.05 indicates a significant difference from the disease group (C = control group, A = alloxan-treated group, M = metformin, A + M = alloxan + metformin, A + G = alloxan + Gynura, and G = G. procumbens).